Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering greater outcomes for individuals with type 2 diabetes. Further study is underway to fully explore the long-term eff